476 related articles for article (PubMed ID: 27521232)
1. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation.
Brehony C; Rodrigues CMC; Borrow R; Smith A; Cunney R; Moxon ER; Maiden MCJ
Vaccine; 2016 Sep; 34(39):4690-4697. PubMed ID: 27521232
[TBL] [Abstract][Full Text] [Related]
2. Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia.
Mowlaboccus S; Perkins TT; Smith H; Sloots T; Tozer S; Prempeh LJ; Tay CY; Peters F; Speers D; Keil AD; Kahler CM
PLoS One; 2016; 11(6):e0158315. PubMed ID: 27355628
[TBL] [Abstract][Full Text] [Related]
3. Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.
Rodrigues CMC; Lucidarme J; Borrow R; Smith A; Cameron JC; Moxon ER; Maiden MCJ
Emerg Infect Dis; 2018 Apr; 24(4):673-682. PubMed ID: 29553330
[TBL] [Abstract][Full Text] [Related]
4. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
[No Abstract] [Full Text] [Related]
5. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
[TBL] [Abstract][Full Text] [Related]
6. [Sequencing analysis of the antigens included in the four-component vaccine against serogroup B meningococcus in Czech isolates of Neisseria meningitidis from 2007-2013].
Křížová P; Musílek M; Vacková Z; Bečvářová Z; Kozáková J
Epidemiol Mikrobiol Imunol; 2014 Feb; 63(1):61-8. PubMed ID: 24730996
[TBL] [Abstract][Full Text] [Related]
7. Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.
Mowlaboccus S; Mullally CA; Richmond PC; Howden BP; Stevens K; Speers DJ; Keil AD; Bjørnstad ON; Perkins TT; Kahler CM
PLoS One; 2017; 12(10):e0186839. PubMed ID: 29065137
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).
Gandhi A; Balmer P; York LJ
Postgrad Med; 2016 Aug; 128(6):548-56. PubMed ID: 27467048
[TBL] [Abstract][Full Text] [Related]
9. Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.
Law DK; Lefebvre B; Gilca R; Deng S; Zhou J; De Wals P; Tsang RS
BMC Microbiol; 2015 Jul; 15():143. PubMed ID: 26204985
[TBL] [Abstract][Full Text] [Related]
10. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R;
Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089
[TBL] [Abstract][Full Text] [Related]
11. Characterization of invasive meningococcal disease case isolates in Atlantic Canada, 2014 to 2020: spatial-temporal variations of clones and predicted meningococcal B vaccine coverage.
Tsang RSW; Law DKS; Zhou J; Haldane D; Garceau R; Zahariadis G; Mead K; Alexander D
J Med Microbiol; 2022 Dec; 71(12):. PubMed ID: 36748536
[No Abstract] [Full Text] [Related]
12. Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
Waśko I; Gołębiewska A; Kiedrowska M; Ronkiewicz P; Wróbel-Pawelczyk I; Kuch A; Hong E; Skoczyńska A
Vaccine; 2020 Feb; 38(8):1943-1952. PubMed ID: 31980191
[TBL] [Abstract][Full Text] [Related]
13. Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland.
Leo S; Lazarevic V; Girard M; Getaz-Jimenez Velasco GC; Gaïa N; Renzi G; Cherkaoui A; Hong E; Taha MK; Schrenzel J
Vaccine; 2020 Jul; 38(33):5324-5331. PubMed ID: 32561121
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal vaccine antigen diversity in global databases.
Brehony C; Hill DM; Lucidarme J; Borrow R; Maiden MC
Euro Surveill; 2015; 20(49):. PubMed ID: 26676305
[TBL] [Abstract][Full Text] [Related]
15. High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines.
Säll O; Olofsson E; Jacobsson S
Vaccine; 2020 Jun; 38(28):4374-4378. PubMed ID: 32414653
[TBL] [Abstract][Full Text] [Related]
16. Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.
Holst J; Comanducci M; Bambini S; Muzzi A; Comandi S; Oksnes J; DeTora L; Pizza M; Rappuoli R; Caugant DA
Vaccine; 2014 May; 32(23):2722-31. PubMed ID: 24631075
[TBL] [Abstract][Full Text] [Related]
17. Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.
Bodini M; Brozzi A; Giuliani M; Nohynek H; Vainio A; Kuusi M; De Paola R; Pizza M; Medini D; Toropainen M; Serino L; Muzzi A
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938694
[TBL] [Abstract][Full Text] [Related]
18. Establishment of the European meningococcal strain collection genome library (EMSC-GL) for the 2011 to 2012 epidemiological year.
Bratcher HB; Brehony C; Heuberger S; Pieridou-Bagatzouni D; Křížová P; Hoffmann S; Toropainen M; Taha MK; Claus H; Tzanakaki G; Erdôsi T; Galajeva J; van der Ende A; Skoczyńska A; Pana M; Vaculíková A; Paragi M; Maiden MC; Caugant DA
Euro Surveill; 2018 May; 23(20):. PubMed ID: 29790460
[TBL] [Abstract][Full Text] [Related]
19. Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.
Cayrou C; Akinduko AA; Mirkes EM; Lucidarme J; Clark SA; Green LR; Cooper HJ; Morrissey J; Borrow R; Bayliss CD
PLoS One; 2018; 13(5):e0197186. PubMed ID: 29847547
[TBL] [Abstract][Full Text] [Related]
20. Meningococcal serogroup B vaccines: Estimating breadth of coverage.
Donald RG; Hawkins JC; Hao L; Liberator P; Jones TR; Harris SL; Perez JL; Eiden JJ; Jansen KU; Anderson AS
Hum Vaccin Immunother; 2017 Feb; 13(2):255-265. PubMed ID: 27960595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
